BIVI

BioVie, Inc. Common Stock

1.14

USD

BIVI Earnings Reports

Positive Surprise Ratio

BIVI beat 7 of 12 last estimates.

58%

Next Report

Tomorrow

Date of Next Report

Feb 09, 2026

Estimate for Q2 26 (Revenue/ EPS)

-$0.82

Implied change from Q1 26 (Revenue/ EPS)

Implied change from Q2 25 (Revenue/ EPS)

+78.26%

BioVie, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, BIVI reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.82 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were BioVie, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?

For Q1 2026, BioVie, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to BioVie, Inc. Common Stock's Q1 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is BioVie, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 09, 2026.

What are the forecasts for BioVie, Inc. Common Stock's next earnings report?

Based on 3 analysts, BioVie, Inc. Common Stock is expected to report EPS of -$0.82 and revenue of -- for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.